Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Cerebral Amyloid Angiopathy

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Cerebral Amyloid Angiopathy:

Pubmed Logo
Vasomotor Reactivity Is Similarly Impaired in Patients with Alzheimer's Disease and Patients with Amyloid Hemorrhage.
ABSTRACT Cerebral amyloid angiopathy (CAA) might alter cerebral...
17th November, 2009
From the Neurology Department, Hospital Alvarez-Buylla, Mieres, Spain J Neuroimaging. 2009 Nov 12.
DOI Direct Link
Prion protein amyloidosis with divergent phenotype associated with two novel nonsense mutations in PRNP.
Stop codon mutations in the gene encoding the prion protein (PRNP) are...
17th November, 2009
Dutch Surveillance Centre for Prion Diseases, University Medical Centre Acta Neuropathol. 2009 Nov 13.
DOI Direct Link
Hypoperfusion and Ischemia in Cerebral Amyloid Angiopathy Documented by 99mTc-ECD Brain Perfusion SPECT.
Cerebral amyloid angiopathy (CAA) is known to be an important cause of...
17th November, 2009
Department of Radiology, College of Medicine, Catholic University of J Nucl Med. 2009 Nov 12.
DOI Direct Link
Age-related brain pathology in Octodon degu: Blood vessel, white matter and Alzheimer-like pathology.
Recently it has been shown that over 3-year-old wild-type South American...
17th November, 2009
Department of Cell Biology, Center for Glial Biology, University of Neurobiol Aging. 2009 Nov 10.
DOI Direct Link
Epidemiological pathology of dementia: attributable-risks at death in the medical research council cognitive function and ageing study.
BACKGROUND: Dementia drug development aims to modulate pathological...
11th November, 2009
Medical Research Council (MRC) Biostatistics, University of Cambridge, PLoS Med. 2009 Nov;6(11):e1000180. Epub 2009 Nov 10.
DOI Direct Link

View more research publications.

Press Releases About Cerebral Amyloid Angiopathy:

BioPortfolio Logo
Reportlinker Adds Alzheimer's and Parkinson's Diseases - A Global Update of Market Trends & Opportunities 18th November, 2009 Reportlinker
NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Alzheimer's and Parkinson's Diseases - A Global Update of Market
China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 11th November, 2009 China Pharma Holdings, Inc.
HAIKOU CITY, China, Nov. 11 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE/AMEX: CPHI), which manufactures, and markets specialty pharmaceutical
EP Global Communications Inc. to Co-Produce and Sponsor the 2009 World Congress on Disabilities Expo 9th November, 2009 EP Global Communications, Inc.
JOHNSTOWN, Pa., Nov. 9 /PRNewswire-FirstCall/ -- EP Global Communications Inc. (the Company) (OTC: EPGL.PK), the parent company of Exceptional Parent (EP) magazine, is pleased to announce that the
Circle K Aces High Golf Tournament - Furthering Life without Limits for People with Disabilities 2nd November, 2009 United Cerebral Palsy (UCP) of Central Arizona
PHOENIX, Nov. 2 /PRNewswire/ -- United Cerebral Palsy (UCP) of Central Arizona has an extraordinary corporate partner in Circle K. UCP has been the beneficiary of Circle K's community
Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology 30th October, 2009 Bayer HealthCare Pharmaceuticals
BANGKOK, Oct. 30 /PRNewswire/ -- Bayer HealthCare presented results from a global Phase II study of florbetaben, its imaging agent in development for the detection of cerebral beta-Amyloid plaques, at

BioNews Results for Cerebral Amyloid Angiopathy:

RSS Logo
BioPortfolio Logo
Neuroimaging Demonstration of Evolving Small Vessel Ischemic Injury in Cerebral Amyloid Angiopathy
MDLinx:  Nov 5 2009 11:19AM Matching: cerebral amyloid angiopathy

Cerebral Amyloid Angiopathy Patents:

USPTO Logo
US Patent No.Title
7514461 Chroman derivatives
7550569 Antibodies that specifically bind to GMAD
7550629 Trifluoromethyl-containing phenylsulfonamide beta amyloid inhibitors
7553831 Compounds to treat Alzheimer's disease
7553972 Benzamide inhibitors of the P2X.sub.7 receptor

View more patents.

Companies working in the area of Cerebral Amyloid Angiopathy from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Neurochem

Neurochem Inc. is a dynamic, highly energized biopharmaceutical company with an exciting vision and future, located in the Parc scientifique et de haute technologie de Laval, in Quebec, Canada.
www.neurochem.com/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Cerebral Amyloid Angiopathy scientists - we have details of around 103 individuals working on Cerebral Amyloid Angiopathy .


This page has been viewed 400 times
Recent Search Terms used to find this page: cerebral amyloid angiopathy trials | amyloid angiopathy | cerebral amyloid treatment mayo | cerebral amyloid treatment mayo | clinical trials for cerebral amyloid angiopathy | amyloid micro angiopathy | amyloid angiopathy | cerebral amyloid angiopathy | cerebral amyloid angiopathy (CAA) | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Cerebral Amyloid Angiopathy across BioPortfolio, or for Cerebral Amyloid Angiopathy Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.